Navigation Links
Immucor Appoints New Board Director
Date:12/16/2009

NORCROSS, Ga., Dec. 16 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Paul D. Mintz, M.D. has been appointed to its board as a new independent director, effective January 1, 2010.

Dr. Mintz has been involved in blood banking and transfusion medicine for more than 30 years. He is a tenured Professor of Pathology and Medicine at the University of Virginia School of Medicine. He also serves as director of the University of Virginia Health System's Clinical Laboratories and Transfusion Medicine Services as well as Chief of the Department of Pathology's Division of Clinical Pathology. Dr. Mintz is also a co-medical director of Virginia Blood Services.

Dr. Mintz has served on numerous national and regional boards and committees throughout his career for such agencies and organizations as the Centers for Medicare and Medicaid Services, the National Blood Foundation and the AABB (formerly the American Association of Blood Banks). He is a past president of AABB and served for several years on its FDA Advisory Committee, including as past chair.

"Paul is the chair of Immucor's Scientific Advisory Board, which provides scientific expertise and strategic counsel on a variety of scientific and technical issues," stated Joseph Rosen, Immucor's Chairman of the Board. "Paul's extensive experience in transfusion medicine and familiarity with Immucor make him a valuable addition to Immucor's Board of Directors."

Dr. Mintz was a recipient of a Transfusion Medicine Academic Award from the National Heart, Lung and Blood Institute. He has authored or co-authored more than 100 journal articles in blood banking and transfusion medicine.

Dr. Mintz will stand for regular election to a one-year term at the Company's next annual shareholders' meeting. The addition of Dr. Mintz expands the Company's board size to eight directors.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.

SOURCE Immucor, Inc.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shareholder Class Action Filed Against Immucor, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
2. Immucor to Announce Fiscal First Quarter Financial Results on Thursday, October 1, 2009
3. Immucor to Present at Upcoming Investor Conferences
4. Immucor Announces Fiscal Fourth Quarter Results
5. Immucor Appoints Chief Operating Officer
6. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
7. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
8. Immucor Announces Fiscal Year 2010 Guidance
9. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
10. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
11. Immucor Receives Subpoena From Department of Justice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... 25, 2017 , ... Lake Park Dental is now accepting new patients with ... Lutz, FL. With the help of this highly-effective, yet convenient system, patients can straighten ... discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and ...
(Date:4/25/2017)... ... 2017 , ... As Spring reignites vigilance against Zika virus-carrying ... Zika virus during pregnancy, as well as other prenatal exposures like cocaine, are ... The Teratology Society is an international and multidisciplinary group of scientists ...
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... , ... April 25, 2017 , ... There is no ... Hospital, according to a special report in the May issue of Consumer Reports focused ... highest quality ranking for results achieved during and after coronary bypass and aortic valve ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the ... Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market ... Low drug registration cost in Latin American countries and ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: